AVCR Stock Overview
Engages in the health data and point-of-care technologies business in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Avricore Health Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.15 |
52 Week High | CA$0.29 |
52 Week Low | CA$0.10 |
Beta | -2.1 |
1 Month Change | 14.81% |
3 Month Change | 24.00% |
1 Year Change | -46.55% |
3 Year Change | -18.42% |
5 Year Change | 121.43% |
Change since IPO | -98.98% |
Recent News & Updates
Recent updates
Shareholder Returns
AVCR | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | -6.1% | 2.3% | 0.4% |
1Y | -46.6% | 50.6% | 10.1% |
Return vs Industry: AVCR underperformed the Canadian Healthcare Services industry which returned 50.2% over the past year.
Return vs Market: AVCR underperformed the Canadian Market which returned 10.3% over the past year.
Price Volatility
AVCR volatility | |
---|---|
AVCR Average Weekly Movement | 14.4% |
Healthcare Services Industry Average Movement | 12.3% |
Market Average Movement | 8.8% |
10% most volatile stocks in CA Market | 17.9% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: AVCR has not had significant price volatility in the past 3 months.
Volatility Over Time: AVCR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company has strategic partnerships with Shoppers Drug Marts and Abbott.
Avricore Health Inc. Fundamentals Summary
AVCR fundamental statistics | |
---|---|
Market cap | CA$15.48m |
Earnings (TTM) | -CA$701.21k |
Revenue (TTM) | CA$3.49m |
4.4x
P/S Ratio-22.1x
P/E RatioIs AVCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVCR income statement (TTM) | |
---|---|
Revenue | CA$3.49m |
Cost of Revenue | CA$2.28m |
Gross Profit | CA$1.20m |
Other Expenses | CA$1.90m |
Earnings | -CA$701.21k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.007 |
Gross Margin | 34.53% |
Net Profit Margin | -20.12% |
Debt/Equity Ratio | 2.0% |
How did AVCR perform over the long term?
See historical performance and comparison